Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

Kelly Doering, Waters Senior Business Manager, discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS. She'll then present three examples of when LC-MS is the preferred method for quantification of insulin analogs based on specificity requirements and the need to multiplex. www.waters.com/dmpk